119 related articles for article (PubMed ID: 11704315)
21. Amifostine modulates radio-induced apoptosis of peripheral blood lymphocytes in head and neck cancer patients.
Saavedra MM; Henríquez-Hernández LA; Lara PC; Pinar B; Rodríguez-Gallego C; Lloret M
J Radiat Res; 2010; 51(5):603-7. PubMed ID: 20699603
[TBL] [Abstract][Full Text] [Related]
22. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
24. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
[TBL] [Abstract][Full Text] [Related]
25. Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy.
Yang FE; Vaida F; Ignacio L; Houghton A; Nauityal J; Halpern H; Sutton H; Vijayakumar S
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):617-17. PubMed ID: 7558950
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
27. Radiation-induced craniofacial bone growth inhibition: efficacy of cytoprotection following a fractionated dose regimen.
La Scala GC; O'Donovan DA; Yeung I; Darko J; Addison PD; Neligan PC; Pang CY; Forrest CR
Plast Reconstr Surg; 2005 Jun; 115(7):1973-85. PubMed ID: 15923846
[TBL] [Abstract][Full Text] [Related]
28. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic damage induced by radiotherapy. Evaluation of protection by amifostine and analysis of chromosome aberrations persistence.
Xunclà M; Barquinero JF; Caballín MR; Craven-Bartle J; Ribas M; de Vega JM; Barrios L
Int J Radiat Biol; 2008 Mar; 84(3):243-51. PubMed ID: 18300025
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
Anné PR
Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial.
Athanassiou H; Antonadou D; Coliarakis N; Kouveli A; Synodinou M; Paraskevaidis M; Sarris G; Georgakopoulos GR; Panousaki K; Karageorgis P; Throuvalas N;
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1154-60. PubMed ID: 12829154
[TBL] [Abstract][Full Text] [Related]
32. A randomized phase II trial of amifostine for head and neck irradiation in lymphoma.
Ng AK; Hickey G; Li S; Neuberg D; Mauch PM
Semin Oncol; 2004 Dec; 31(6 Suppl 18):20-4. PubMed ID: 15726518
[TBL] [Abstract][Full Text] [Related]
33. Amifostine protects bone marrow from benzene-induced hematotoxicity in mice.
Yu K; Yang KY; Ren XZ; Chen Y; Liu XH
Int J Toxicol; 2007; 26(4):315-23. PubMed ID: 17661222
[TBL] [Abstract][Full Text] [Related]
34. Navigating external beam radiation therapy for head and neck cancer.
Cady J
Clin J Oncol Nurs; 2005 Jun; 9(3):362-6. PubMed ID: 15973848
[No Abstract] [Full Text] [Related]
35. [An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors].
Niibe H; Takahashi I; Mitsuhashi N; Miyaishi K; Itoh J; Maehara Y; Nakajima N; Suto H; Sakaino K; Matsuura S
Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):984-93. PubMed ID: 2997351
[No Abstract] [Full Text] [Related]
36. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
Jellema AP; Slotman BJ; Muller MJ; Leemans CR; Smeele LE; Hoekman K; Aaronson NK; Langendijk JA
Cancer; 2006 Aug; 107(3):544-53. PubMed ID: 16804929
[TBL] [Abstract][Full Text] [Related]
37. Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
Antonadou D; Throuvalas N; Petridis A; Bolanos N; Sagriotis A; Synodinou M
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):402-8. PubMed ID: 12957251
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
Mell LK; Movsas B
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1341-50. PubMed ID: 18798703
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
Vujaskovic Z; Feng QF; Rabbani ZN; Samulski TV; Anscher MS; Brizel DM
Exp Lung Res; 2002; 28(7):577-90. PubMed ID: 12396250
[TBL] [Abstract][Full Text] [Related]
40. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
